Global Energy-based Therapeutics Market Insights, Forecast to 2025
Table of Contents
1 Study Coverage
- 1.1 Energy-based Therapeutics Product
- 1.2 Market Segments
- 1.3 Key Manufacturers Covered
- 1.4 Market by Type
- 1.4.1 Global Energy-based Therapeutics Market Size Growth Rate by Product
- 1.4.2 Microwave
- 1.4.3 Radiofrequency
- 1.4.4 Hydro-Mechanical
- 1.4.5 Cryotherapy
- 1.4.6 Thermal
- 1.4.7 Ultrasound
- 1.5 Market by End User
- 1.5.1 Global Energy-based Therapeutics Market Size Growth Rate by End User
- 1.5.2 Hospital
- 1.5.3 Beauty Parlor
- 1.5.4 Domestic
- 1.6 Study Objectives
- 1.7 Years Considered
2 Executive Summary
- 2.1 Global Energy-based Therapeutics Market Size
- 2.1.1 Global Energy-based Therapeutics Revenue 2014-2025
- 2.1.2 Global Energy-based Therapeutics Sales 2014-2025
- 2.2 Energy-based Therapeutics Growth Rate by Regions
- 2.2.1 Global Energy-based Therapeutics Sales by Regions
- 2.2.2 Global Energy-based Therapeutics Revenue by Regions
3 Breakdown Data by Manufacturers
- 3.1 Energy-based Therapeutics Sales by Manufacturers
- 3.1.1 Energy-based Therapeutics Sales by Manufacturers
- 3.1.2 Energy-based Therapeutics Sales Market Share by Manufacturers
- 3.1.3 Global Energy-based Therapeutics Market Concentration Ratio (CR5 and HHI)
- 3.2 Energy-based Therapeutics Revenue by Manufacturers
- 3.2.1 Energy-based Therapeutics Revenue by Manufacturers (2014-2019)
- 3.2.2 Energy-based Therapeutics Revenue Share by Manufacturers (2014-2019)
- 3.3 Energy-based Therapeutics Price by Manufacturers
- 3.4 Energy-based Therapeutics Manufacturing Base Distribution, Product Types
- 3.4.1 Energy-based Therapeutics Manufacturers Manufacturing Base Distribution, Headquarters
- 3.4.2 Manufacturers Energy-based Therapeutics Product Type
- 3.4.3 Date of International Manufacturers Enter into Energy-based Therapeutics Market
- 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Product
- 4.1 Global Energy-based Therapeutics Sales by Product
- 4.2 Global Energy-based Therapeutics Revenue by Product
- 4.3 Energy-based Therapeutics Price by Product
5 Breakdown Data by End User
- 5.1 Overview
- 5.2 Global Energy-based Therapeutics Breakdown Data by End User
6 North America
- 6.1 North America Energy-based Therapeutics by Countries
- 6.1.1 North America Energy-based Therapeutics Sales by Countries
- 6.1.2 North America Energy-based Therapeutics Revenue by Countries
- 6.1.3 United States
- 6.1.4 Canada
- 6.1.5 Mexico
- 6.2 North America Energy-based Therapeutics by Product
- 6.3 North America Energy-based Therapeutics by End User
7 Europe
- 7.1 Europe Energy-based Therapeutics by Countries
- 7.1.1 Europe Energy-based Therapeutics Sales by Countries
- 7.1.2 Europe Energy-based Therapeutics Revenue by Countries
- 7.1.3 Germany
- 7.1.4 France
- 7.1.5 UK
- 7.1.6 Italy
- 7.1.7 Russia
- 7.2 Europe Energy-based Therapeutics by Product
- 7.3 Europe Energy-based Therapeutics by End User
8 Asia Pacific
- 8.1 Asia Pacific Energy-based Therapeutics by Countries
- 8.1.1 Asia Pacific Energy-based Therapeutics Sales by Countries
- 8.1.2 Asia Pacific Energy-based Therapeutics Revenue by Countries
- 8.1.3 China
- 8.1.4 Japan
- 8.1.5 Korea
- 8.1.6 India
- 8.1.7 Australia
- 8.1.8 Indonesia
- 8.1.9 Malaysia
- 8.1.10 Philippines
- 8.1.11 Thailand
- 8.1.12 Vietnam
- 8.1.13 Singapore
- 8.2 Asia Pacific Energy-based Therapeutics by Product
- 8.3 Asia Pacific Energy-based Therapeutics by End User
9 Central & South America
- 9.1 Central & South America Energy-based Therapeutics by Countries
- 9.1.1 Central & South America Energy-based Therapeutics Sales by Countries
- 9.1.2 Central & South America Energy-based Therapeutics Revenue by Countries
- 9.1.3 Brazil
- 9.2 Central & South America Energy-based Therapeutics by Product
- 9.3 Central & South America Energy-based Therapeutics by End User
10 Middle East and Africa
- 10.1 Middle East and Africa Energy-based Therapeutics by Countries
- 10.1.1 Middle East and Africa Energy-based Therapeutics Sales by Countries
- 10.1.2 Middle East and Africa Energy-based Therapeutics Revenue by Countries
- 10.1.3 GCC Countries
- 10.1.4 Turkey
- 10.1.5 Egypt
- 10.1.6 South Africa
- 10.2 Middle East and Africa Energy-based Therapeutics by Product
- 10.3 Middle East and Africa Energy-based Therapeutics by End User
11 Company Profiles
- 11.1 Johnson & Johnson
- 11.1.1 Johnson & Johnson Company Details
- 11.1.2 Company Business Overview
- 11.1.3 Johnson & Johnson Energy-based Therapeutics Sales, Revenue and Gross Margin (2014-2019)
- 11.1.4 Johnson & Johnson Energy-based Therapeutics Products Offered
- 11.1.5 Johnson & Johnson Recent Development
- 11.2 Lumenis
- 11.2.1 Lumenis Company Details
- 11.2.2 Company Business Overview
- 11.2.3 Lumenis Energy-based Therapeutics Sales, Revenue and Gross Margin (2014-2019)
- 11.2.4 Lumenis Energy-based Therapeutics Products Offered
- 11.2.5 Lumenis Recent Development
- 11.3 Syneron Medical
- 11.3.1 Syneron Medical Company Details
- 11.3.2 Company Business Overview
- 11.3.3 Syneron Medical Energy-based Therapeutics Sales, Revenue and Gross Margin (2014-2019)
- 11.3.4 Syneron Medical Energy-based Therapeutics Products Offered
- 11.3.5 Syneron Medical Recent Development
- 11.4 Abbott Medical Optics
- 11.4.1 Abbott Medical Optics Company Details
- 11.4.2 Company Business Overview
- 11.4.3 Abbott Medical Optics Energy-based Therapeutics Sales, Revenue and Gross Margin (2014-2019)
- 11.4.4 Abbott Medical Optics Energy-based Therapeutics Products Offered
- 11.4.5 Abbott Medical Optics Recent Development
- 11.5 Alcon
- 11.5.1 Alcon Company Details
- 11.5.2 Company Business Overview
- 11.5.3 Alcon Energy-based Therapeutics Sales, Revenue and Gross Margin (2014-2019)
- 11.5.4 Alcon Energy-based Therapeutics Products Offered
- 11.5.5 Alcon Recent Development
- 11.6 Alna Medical System
- 11.6.1 Alna Medical System Company Details
- 11.6.2 Company Business Overview
- 11.6.3 Alna Medical System Energy-based Therapeutics Sales, Revenue and Gross Margin (2014-2019)
- 11.6.4 Alna Medical System Energy-based Therapeutics Products Offered
- 11.6.5 Alna Medical System Recent Development
- 11.7 Angiodynamic
- 11.7.1 Angiodynamic Company Details
- 11.7.2 Company Business Overview
- 11.7.3 Angiodynamic Energy-based Therapeutics Sales, Revenue and Gross Margin (2014-2019)
- 11.7.4 Angiodynamic Energy-based Therapeutics Products Offered
- 11.7.5 Angiodynamic Recent Development
- 11.8 Angiodynamics
- 11.8.1 Angiodynamics Company Details
- 11.8.2 Company Business Overview
- 11.8.3 Angiodynamics Energy-based Therapeutics Sales, Revenue and Gross Margin (2014-2019)
- 11.8.4 Angiodynamics Energy-based Therapeutics Products Offered
- 11.8.5 Angiodynamics Recent Development
- 11.9 Atricure
- 11.9.1 Atricure Company Details
- 11.9.2 Company Business Overview
- 11.9.3 Atricure Energy-based Therapeutics Sales, Revenue and Gross Margin (2014-2019)
- 11.9.4 Atricure Energy-based Therapeutics Products Offered
- 11.9.5 Atricure Recent Development
- 11.10 Biolase
- 11.10.1 Biolase Company Details
- 11.10.2 Company Business Overview
- 11.10.3 Biolase Energy-based Therapeutics Sales, Revenue and Gross Margin (2014-2019)
- 11.10.4 Biolase Energy-based Therapeutics Products Offered
- 11.10.5 Biolase Recent Development
12 Future Forecast
- 12.1 Energy-based Therapeutics Market Forecast by Regions
- 12.1.1 Global Energy-based Therapeutics Sales Forecast by Regions 2019-2025
- 12.1.2 Global Energy-based Therapeutics Revenue Forecast by Regions 2019-2025
- 12.2 Energy-based Therapeutics Market Forecast by Product
- 12.2.1 Global Energy-based Therapeutics Sales Forecast by Product 2019-2025
- 12.2.2 Global Energy-based Therapeutics Revenue Forecast by Product 2019-2025
- 12.3 Energy-based Therapeutics Market Forecast by End User
- 12.4 North America Energy-based Therapeutics Forecast
- 12.5 Europe Energy-based Therapeutics Forecast
- 12.6 Asia Pacific Energy-based Therapeutics Forecast
- 12.7 Central & South America Energy-based Therapeutics Forecast
- 12.8 Middle East and Africa Energy-based Therapeutics Forecast
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
- 13.1 Market Opportunities and Drivers
- 13.2 Market Challenges
- 13.3 Market Risks/Restraints
- 13.4 Macroscopic Indicators
14 Value Chain and Sales Channels Analysis
- 14.1 Value Chain Analysis
- 14.2 Energy-based Therapeutics Customers
- 14.3 Sales Channels Analysis
- 14.3.1 Sales Channels
- 14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
- 16.1 Research Methodology
- 16.1.1 Methodology/Research Approach
- 16.1.2 Data Source
- 16.2 Author Details
Energy-based therapeutics involves the use of energy fields.
Schools
Public Buildings
Large Warehouse Complexes
Hotels
increased demand for aesthetic surgeries.
The global Energy-based Therapeutics market is valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025. The objectives of this study are to define, segment, and project the size of the Energy-based Therapeutics market based on company, product type, end user and key regions.
This report studies the global market size of Energy-based Therapeutics in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Energy-based Therapeutics in these regions.
This research report categorizes the global Energy-based Therapeutics market by top players/brands, region, type and end user. This report also studies the global Energy-based Therapeutics market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.
The following manufacturers are covered in this report, with sales, revenue, market share for each company:
Johnson & Johnson
Lumenis
Syneron Medical
Abbott Medical Optics
Alcon
Alna Medical System
Angiodynamic
Angiodynamics
Atricure
Biolase
Market size by Product
Microwave
Radiofrequency
Hydro-Mechanical
Cryotherapy
Thermal
Ultrasound
Market size by End User
Hospital
Beauty Parlor
Domestic
Market size by Region
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Singapore
Malaysia
Philippines
Thailand
Vietnam
Europe
Germany
France
UK
Italy
Spain
Russia
Central & South America
Brazil
Rest of Central & South America
Middle East & Africa
GCC Countries
Turkey
Egypt
South Africa
The study objectives of this report are:
To study and analyze the global Energy-based Therapeutics market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.
To understand the structure of Energy-based Therapeutics market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
Focuses on the key global Energy-based Therapeutics companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
To project the value and sales volume of Energy-based Therapeutics submarkets, with respect to key regions.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
In this study, the years considered to estimate the market size of Energy-based Therapeutics are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
This report includes the estimation of market size for value (million US$) and volume (K Units). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Energy-based Therapeutics market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.